Grant: Project Grant
University of Ottawa
$814,725.00
Defining the Role of Signalling to ATG16L1 in Anti-Microbial Autophagy and Crohn's Disease
FY 2016-17
Summary
Autophagy is a highly regulated degradative process in which the cell digests resident or foreign intracellular components. The autophagy pathway is an integral adaptive response to counter several potentially harmful cellular conditions including: starvation, infection, accumulation of toxic protein aggregates, and organelle damage. Dysregulation of the autophagy pathway has been implicated in several diseases including Crohn's Disease, cancer, neurodegeneration and cardiomyopathy. However, fundamental gaps exist in our understanding of how the autophagy pathway is regulated (or dysregulated in disease) that have largely precluded our ability to pharmacologically target perturbations of this promising pathway. The first goal of this project is to understand how a network of autophagy-related genes coordinate the anti-microbial response. Our second goal is to validate a targeted treatment strategy to rescue autophagy defects in CD-patients.
Department
Program
Project Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
356629
Name
Russell Ryan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Defining the Role of Signalling to ATG16L1 in Anti-Microbial Autophagy and Crohn's Disease
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$814,725
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Anti-Microbial Response; Autophagy; Inflammation; Nutrient-Sensitive Kinases; Signal Transduction; Xenophagy
Abstract
Autophagy is a highly regulated degradative process in which the cell digests resident or foreign intracellular components. The autophagy pathway is an integral adaptive response to counter several potentially harmful cellular conditions including: starvation, infection, accumulation of toxic protein aggregates, and organelle damage. Dysregulation of the autophagy pathway has been implicated in several diseases including Crohn's Disease, cancer, neurodegeneration and cardiomyopathy. However, fundamental gaps exist in our understanding of how the autophagy pathway is regulated (or dysregulated in disease) that have largely precluded our ability to pharmacologically target perturbations of this promising pathway. The first goal of this project is to understand how a network of autophagy-related genes coordinate the anti-microbial response. Our second goal is to validate a targeted treatment strategy to rescue autophagy defects in CD-patients.
Competitiondate
201610
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Russell, Ryan
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $814,725~ $0~